Cancer Patients Invited to Share Their Experiences in Conversations About Surgery

Todd Harper: Cancer Research Giving Day Raised $671,000 Towards Cancer Research

KEYNOTE-091 (PEARLS): Adjuvant Pembrolizumab in Resected NSCLC

Cherie Myatt Steps Into Interim President Role at Vaniam Group

Hope 4 Kids Albania: Committed to Ensuring Access to Care for Every Child Fighting Cancer

Oncology News, Insights, Stories by OncoDaily

KEYNOTE-905/EV-303 Trial: Perioperative Enfortumab Vedotin and Pembrolizumab in Muscle-Invasive Bladder Cancer
New Paper Alert

KEYNOTE-905/EV-303 Trial: Perioperative Enfortumab Vedotin and Pembrolizumab in Muscle-Invasive Bladder Cancer

Donjeta Bali
Voices

Donjeta Bali: United, We Make Every Child’s Victory Possible

Sana Al Sukhun
OncoDaily Pulse

Call for Papers: Special Series on Cancer in the Middle East in 2026

Pat Soon-Shiong Marks a New Era of Cancer Immunotherapy Acces

Jasmine Kamboj: Key Career Lessons from Dr Herbert Loong on Service, Mentorship, and Collaboration

Mark Dawson is Appointed Head of Roche Pharma Research and Early Development

James R. Downing is Stepping Down as CEO After 12 Years at St. Jude

ESTRO Elections 2026: Who Will Lead the Future of Radiation Oncology?

CheckMate 649: 5-Year Results of First-Line Nivolumab Plus Chemotherapy in Advanced Gastric, GEJ, and Esophageal Adenocarcinoma

Nominations Now Open for the 2026-2028 Board of Directors and President-Elect - UICC

Cervical Cancer 2026
OncoThon 2026
Advances in The Immunotherapy of Cold Tumors
OncoDaily 100
Act 4 Children
Grand Rounds GI
OncoDaily Party: Berlin 2025
awards
awards
awards
awards
awards
awards

Voices
Amol Akhade

Amol Akhade: Stage Shifts, Screening, and What Matters Most

Listen To Health Experts, Not Influencers or Political Figures

Ranjit Manchanda on NBN Pathogenic Variants and Ovarian Cancer Risk

Elevate Your Oncology Expertise with the Multidisciplinary Masterclass – European School of Oncology

Steps Toward Prevention and Early Diagnosis - Childhood Cancer International - Europe

How Early Detection and Intervention are Reshaping Cancer Prevention - NFCR

Stacey Tinianov Celebrates Multidisciplinary Efforts to Hear Patients at MHNCS 2026

FDA Approvals
FDA-Optune Pax

PANOVA-3 Leads to FDA Approval of Optune Pax in Locally Advanced Pancreatic Cancer

Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Receives FDA Fast Track Designation in FGF19-Overexpressing Advanced HCC

Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy

FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC

FDA Approved Rucaparib for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer

OncoDaily 100
100 Most Influential CEOs

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Cancer Grand Challenges Conference - Cancer and the Host

Cancer Grand Challenges

17 Jun
Cancer Grand Challenges

International Conference on Oncology, Cardiology and Critical Care Strategies (ICOCCS 2026)

Institute for Global Academic Excellence (IGAE)

05 Mar
ICOCCS 2026

The Association of Cancer Physicians (UK Society for Medical Oncology) Conference 2026

Association of Cancer Physicians

16 Apr
Association of Cancer Physicians

The Early Detection of Cancer Conference 2026

Cancer Research UK

06 Oct
cancer

The Cancer Prevention Research Conference 2026

Cancer Research UK

03 Jun
Cancer Prevention

Immune-oncology
The Myth of Lifelong Immunotherapy

The Myth of Lifelong Immunotherapy: Is It Safe to Stop Treatment After Response?

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The "Off-the-Shelf" Revolution: How iNKT Cell Therapy agenT-797 is Reprogramming the Fight Against Solid Tumors

OncoDaily TV
Childhood Cancer

Saving One Million Children: WHO’s Global Initiative for Childhood Cancer with Dr. Catherine Lam

Jeffrey Bluestone

Inside the Mind of Jeffrey Bluestone: Lessons From a Lifetime in Immunology

Princess Dina Mired and Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: Dr. Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

minister

When Minister is also your treating Doctor – Hosams Abu Meri

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Dr. Navid Madani

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Prof. Kofi Mensah Nyarko

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Mina S. Sedrak

Mina S. Sedrak: Shaping the Future of Cancer and Aging Research, Redefining Survivorship

Yuman Fong

Yuman Fong: Exclusive Interview on Innovation, Mentorship and the Future of Surgical Oncology

Immunotherapy in Nigeria

Opening New Frontiers for Cancer Care in Africa: Bringing Colorectal Cancer Immunotherapy in Nigeria

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

Not To Miss
OncoDaily Weekly

Oncology This Week: OncoDaily Weekly Feb 9-15, 2026

ASH Highlights 2026: Insights from Dr Heghine Khachatryan

International Childhood Cancer Day 2026: Powerful Voices, Lifesaving Hope

International Day of Women and Girls in Science 2026

15 Posts Not To Miss from AMSTRO 2026

Oncology This Week: OncoDaily Weekly Feb 2-8, 2026

Exciting News: OncoDaily's Managing Editor Dr Elen Baloyan Releases Her 1st Mini-EP

OncoGrants
Horizon Europe Mission Cancer: CANCER-03 Pragmatic Clinical Trials for Refractory Cancers

Horizon Europe Mission Cancer: CANCER-03 Pragmatic Clinical Trials for Refractory Cancers

Horizon Europe Mission Cancer: CANCER-01 Virtual Human Twin Models for Cancer Research

Horizon Europe Mission Cancer: CANCER-01 Virtual Human Twin Models for Cancer Research

SickKids Meagan Bebenek Neuro-Oncology Fellowship

SickKids Meagan Bebenek Neuro-Oncology Fellowship

2026 AIM-HI BRACE Award Venture Competition

2026 AIM-HI BRACE Award Venture Competition

2026 AIM-HI Women’s Venture Competition

2026 AIM-HI Women’s Venture Competition

2026 Cancer Center at Illinois Seed Grant Program

2026 Cancer Center at Illinois Seed Grant Program

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Sarkis Meterissian

Sarkis Meterissian

Oncologists Location Montreal, Canada
Florian Lordick

Florian Lordick

Oncologists Location Leipzig, Germany
Rahat Ul Ain

Rahat Ul Ain

Oncologists Location Lahore, Pakistan
Chi-kong Li

Li Chi-kong

Oncologists Location Hong Kong, China
Tezer Kutluk

M. Tezer Kutluk

Oncologists Location Ankara, Türkiye
Zainab Shinkafi-Bagudu

Zainab Shinkafi-Bagudu

Oncologists Location Abuja, Nigeria
Roupen Odabashian

Roupen Odabashian

Oncologists Location Detroit, USA
Ting Bao

Ting Bao

Oncologists Location Boston, USA

Oncology Drugs
RYBREVANT FASPRO monthly amivantamab

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

GSK5764227 (HS-20093): Clinical Development of a Next-Generation B7-H3 Directed Antibody–Drug Conjugate

Daraxonrasib (RMC-6236): Clinical Development of a RAS(ON) Inhibitor Advancing Precision Therapy in RAS-Driven Solid Tumors

Daraxonrasib (RMC-6236): A New Targeted Treatment Being Studied for RAS-Driven Cancers

Anbenitamab (KN026): A Patient-Friendly Guide to a New HER2-Targeted Treatment

Anbenitamab (KN026): A Deep Dive Into a Bispecific HER2 Antibody Redefining Targeted Therapy

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
KRAS G12D Drives Early TNFα-Mediated Niche Programming in Pancreatic Tumorigenesis

KRAS G12D Drives Early TNFα-Mediated Niche Programming in Pancreatic Tumorigenesis

CheckMate 649

CheckMate 649: 5-Year Results of First-Line Nivolumab Plus Chemotherapy in Advanced Gastric, GEJ, and Esophageal Adenocarcinoma

KEYNOTE-905/EV-303 Trial: Perioperative Enfortumab Vedotin and Pembrolizumab in Muscle-Invasive Bladder Cancer

KEYNOTE-905/EV-303 Trial: Perioperative Enfortumab Vedotin and Pembrolizumab in Muscle-Invasive Bladder Cancer

Napoli 3

NAPOLI 3 Subgroup Analysis: NALIRIFOX in Older Patients With Metastatic Pancreatic Cancer

KEYVIBE-010 Trial

KEYVIBE-010 Trial: Vibostolimab–Pembrolizumab vs Pembrolizumab in Adjuvant High-Risk Melanoma

SBRT

Biochemical Control and 2-Year Tolerability After SBRT for Localized Prostate Cancer

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-002-0204-6423

Extracorporeal membrane oxygenation in the management of oncologic critical illness
Review

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7103

Dosimetric Comparison of 5-, 7-, and 9-Field SIB-IMRT Plans in Prostate Cancer Using 100% Isodose-Based Target Evaluation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6652

Radiation‐induced Lung Toxicity: A Crucial Problem in Thoracic Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7089

Hippocampus Sparing for Patients Undergoing Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma in Morocco: A Dosimetric Study
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6686

Optimizing Quality of Life in Cervical Cancer Survivors: A Comparative Study of Vaginal Doses Delivered Using Three HDR Brachytherapy Applicators
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6503

Assessment of MOSFET Detectors in In-Vivo Dosimetry for VMAT Total Body Irradiation
Abstracts